Notably, the roles of other nAChR modulators such as Lypd6 [15], Lypd6b [51], and SLURP-1 [17,19], as well as PSCA, in dysregulation of the cholinergic system and AD progression is not studied yet. Here, LYPD6 is linked to Alzheimer disease.